SHC250117C25000
- 0.90
- 0.000.00%
Sotera Health Company Newsroom
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Goldman Sachs Initiates Sotera Health Company(SHC.US) With Hold Rating, Announces Target Price $14
Jefferies Maintains Sotera Health Company(SHC.US) With Buy Rating, Cuts Target Price to $15
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $18
KeyBanc Maintains Sotera Health Company(SHC.US) With Hold Rating
Sotera Health Analyst Ratings
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Piper Sandler Maintains Sotera Health Company(SHC.US) With Hold Rating, Raises Target Price to $15
Sotera Health (SHC) Gets a Buy From RBC Capital
Sotera Health Is Maintained at Buy by Citigroup
Sotera Health Analyst Ratings
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Jefferies Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $18
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $18
Sotera Health (SHC) Gets a Buy From Barclays
Citi Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $20
Sotera Health Analyst Ratings
RBC Capital Reiterates Outperform on Sotera Health, Maintains $17 Price Target
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $17